According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (RXRX -3.49%) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

Since version 0.8.6 of the jdbc artifact. The sql command EXPLAIN doesnt return any resultset. Ive tried both the version 0.9.0 and 0.9.1 of the jdbc artifact and its the same behavior. The 0.8.5 i ...